KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Non-Current Assets (2016 - 2026)

Amgen has reported Non-Current Assets over the past 18 years, most recently at $61.0 billion for Q1 2026.

  • For Q1 2026, Non-Current Assets fell 2.26% year-over-year to $61.0 billion; the TTM value through Mar 2026 reached $246.0 billion, down 2.8%, while the annual FY2025 figure was $61.5 billion, 2.04% down from the prior year.
  • Non-Current Assets for Q1 2026 was $61.0 billion at Amgen, down from $61.5 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $66.8 billion in Q4 2023 and troughed at $39.6 billion in Q3 2022.
  • A 5-year average of $54.3 billion and a median of $61.2 billion in 2025 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: soared 55.64% in 2023 and later decreased 6.01% in 2024.
  • Year by year, Non-Current Assets stood at $42.9 billion in 2022, then soared by 55.64% to $66.8 billion in 2023, then fell by 6.01% to $62.8 billion in 2024, then decreased by 2.04% to $61.5 billion in 2025, then fell by 0.81% to $61.0 billion in 2026.
  • Business Quant data shows Non-Current Assets for AMGN at $61.0 billion in Q1 2026, $61.5 billion in Q4 2025, and $62.3 billion in Q3 2025.